Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CRDLCRDL
17 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CARDIOL THERAPEUTICS INC

CITADEL ADVISORS LLC holds 796,529 shares of CRDL (CARDIOL THERAPEUTICS INC), worth $844,320 as of 2026-Q2. The position was decreased (-2.9% shares). CRDL represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$844,320

Current Shares

796,529

Total Value Change

+$516,320

Total Shares Change

+619,460

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
796,529
-2.9%
$844,3200.0%$1.06
0
2026-Q1
New
819,904
-
$1.1M0.0%$1.01
35
2025-Q4
Exited
0
-100.0%
$00.0%$0.97
0
2025-Q3
New
463,462
-
$495,9040.0%$1.14
33
2025-Q1
Exited
0
-100.0%
$00.0%$0.96
0
2024-Q4
Increased
38,110
+512.6%
$48,7810.0%$1.28
22
2024-Q3
Decreased
6,221
-76.2%
$12,3180.0%$2.07
0
2024-Q2
Decreased
26,187
-56.6%
$52,8980.0%$2.02
0
2024-Q1
New
60,398
-
$109,3200.0%$1.81
33
2023-Q3
Exited
0
-100.0%
$00.0%$0.89
0
2023-Q2
Decreased
17,743
-5.2%
$15,7910.0%$0.89
0
2023-Q1
New
18,716
-
$9,1200.0%$0.49
26
2022-Q4
Exited
0
-100.0%
$00.0%$0.51
0
2022-Q3
Increased
46,204
+93.4%
$48,0000.0%$1.03
22
2022-Q2
Decreased
23,891
-16.0%
$32,0000.0%$1.36
0
2022-Q1
Decreased
28,452
-83.9%
$44,0000.0%$1.47
0
2021-Q4
New
177,069
-
$328,0000.0%$1.83
33

Other major holders of CRDL: Mirae Asset Global Investments Co., Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used